WT1 protein is cleaved by caspase-3 in apoptotic leukemic cells

References

• Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 1990;60:509–520.
   PubMed Web of Science ®Google Scholar
• Yang L, Han Y, Suarez Saiz F, et al. A tumor suppressor and oncogene: the WT1 story. Leukemia. 2007;21:868–876.
   PubMed Web of Science ®Google Scholar
• Wu C, Zhu W, Qian J, et al. WT1 promotes invasion of NSCLC via suppression of CDH1. J Thorac Oncol. 2013;8:1163–1169.
   PubMed Web of Science ®Google Scholar
• Tuna M, Chavez-Reyes A, Tari AM. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Oncogene. 2005;24:1648–1652.
   PubMed Web of Science ®Google Scholar
• Bergmann L, Miething C, Maurer U, et al. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood. 1997;90:1217–1225.
   PubMed Web of Science ®Google Scholar
• Ostergaard M, Olesen LH, Hasle H, et al. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients – results from a single-centre study. Br J Haematol. 2004;125:590–600.
   PubMed Web of Science ®Google Scholar
• Cilloni D, Gottardi E, De Micheli D, et al. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia. 2002;16:2115–2121.
   PubMed Web of Science ®Google Scholar
• Luo S, Yu K, Yan QX, et al. Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia. Leuk Lymphoma. 2014;55:349–357.
   PubMed Web of Science ®Google Scholar
• Hossain A, Nixon M, Kuo MT, et al. N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia. J Biol Chem. 2006;281:28122–28130.
   PubMed Web of Science ®Google Scholar
• Loeb DM. WT1 influences apoptosis through transcriptional regulation of Bcl-2 family members. Cell Cycle. 2006;5:1249–1253.
   PubMed Web of Science ®Google Scholar
• Wu C, Wang S, Xu C, et al. WT1 enhances proliferation and impedes apoptosis in KRAS mutant NSCLC via targeting cMyc. Cell Physiol Biochem. 2015;35:647–662.
   PubMed Web of Science ®Google Scholar
• Nishida S, Hosen N, Shirakata T, et al. AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1. Blood. 2006;107:3303–3312.
   PubMed Web of Science ®Google Scholar
• Yamagami T, Sugiyama H, Inoue K, et al. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood. 1996;87:2878–2884.
   PubMed Web of Science ®Google Scholar
• Hubinger G, Schmid M, Linortner S, et al. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells. Exp Hematol. 2001;29:1226–1235.
   PubMed Web of Science ®Google Scholar
• Elmaagacli AH, Koldehoff M, Peceny R, et al. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells. Haematologica. 2005;90:326–334.
   PubMed Web of Science ®Google Scholar
• Bansal H, Bansal S, Rao M, et al. Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias. Blood. 2010;116:4591–4599.
   PubMed Web of Science ®Google Scholar
• Luthi AU, Martin SJ. The CASBAH: a searchable database of caspase substrates. Cell Death Differ. 2007;14:641–650.
   PubMed Web of Science ®Google Scholar
• Lu Y, Peng ZG, Yuan TT, et al. Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity. Leukemia. 2008;22:378–386.
   PubMed Web of Science ®Google Scholar
• Yun N, Kim C, Cha H, et al. Caspase-3-mediated cleavage of PICOT in apoptosis. Biochem Biophys Res Commun. 2013;432:533–538.
   PubMed Web of Science ®Google Scholar
• Solier S, Pommier Y. MDC1 cleavage by caspase-3: a novel mechanism for inactivating the DNA damage response during apoptosis. Cancer Res. 2011;71:906–913.
   PubMed Web of Science ®Google Scholar
• Azuma H, Ikebuchi K, Yamaguchi M, et al. Comparison of sensitivity to ultraviolet B irradiation between human lymphocytes and hematopoietic stem cells. Blood. 2000;96:2632–2634.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang J, Li X, et al. Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms. Oncol Rep. 2014;32:2680–2686.
   PubMed Web of Science ®Google Scholar
• Svedberg H, Chylicki K, Baldetorp B, et al. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Oncogene. 1998;16:925–932.
   PubMed Web of Science ®Google Scholar
• Hartkamp J, Carpenter B, Roberts SG. The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi. Mol Cell. 2010;37:159–171.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Imai Y, Nakayama H, et al. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell. 2001;8:613–621.
   PubMed Web of Science ®Google Scholar
• Han Y, San-Marina S, Liu J, et al. Transcriptional activation of c-myc proto-oncogene by WT1 protein. Oncogene. 2004;23:6933–6941.
   PubMed Web of Science ®Google Scholar
• Mayo MW, Wang CY, Drouin SS, et al. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J. 1999;18:3990–4003.
   PubMed Web of Science ®Google Scholar
• Glienke W, Maute L, Koehl U, et al. Effective treatment of leukemic cell lines with wt1 siRNA. Leukemia. 2007;21:2164–2170.
   PubMed Web of Science ®Google Scholar
• Semsri S, Krig SR, Kotelawala L, et al. Inhibitory mechanism of pure curcumin on Wilms' tumor 1 (WT1) gene expression through the PKCα signaling pathway in leukemic K562 cells. FEBS Lett. 2011;585:2235–2242.
   PubMed Web of Science ®Google Scholar
• Ethell DW, Bossy-Wetzel E, Bredesen DE. Caspase 7 can cleave tumor necrosis factor receptor-I (p60) at a non-consensus motif, in vitro. Biochim Biophys Acta. 2001;1541:231–238.
   PubMed Web of Science ®Google Scholar
• Krippner-Heidenreich A, Talanian RV, Sekul R, et al. Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochem J. 2001;358:705–715.
   PubMed Web of Science ®Google Scholar
• Dechsukhum C, Ware JL, Ferreira-Gonzalez A, et al. Detection of a novel truncated WT1 transcript in human neoplasia. Mol Diagn. 2000;5:117–128.
   PubMedGoogle Scholar
• Lopotova T, Nadvornikova S, Zackova M, et al. N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia. Leuk Res. 2012;36:e81–e83.
   PubMed Web of Science ®Google Scholar
• Day TW, Wu CH, Safa AR. Etoposide induces protein kinase C delta- and caspase-3-dependent apoptosis in neuroblastoma cancer cells. Mol Pharmacol. 2009;76:632–640.
   PubMed Web of Science ®Google Scholar
• Fattman CL, Delach SM, Dou QP, et al. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis. Oncogene. 2001;20:2918–2926.
   PubMed Web of Science ®Google Scholar